Animal and model systems for studying cystic fibrosis

Journal of Cystic Fibrosis

Volumn 17, Issue 2, 2018, Pages S28-S34

  Rosen, Bradley H ^a   Chanson, Marc ^b   Gawenis, Lara R ^c,d   Liu, Jinghua ^c   Sofoluwe, Aderonke ^b   Zoso, Alice ^b   Engelhardt, John F ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITY OF MISSOURI   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

Author keywords

Animal models; Cellular systems; CF lung disease; Gene editing; Pancreatic disease

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL MODEL; CYSTIC FIBROSIS; DISEASE MODEL; GENE EDITING; GENETIC ENGINEERING; IN VITRO STUDY; LIVER DISEASE; LUNG DISEASE; NONHUMAN; PANCREAS DISEASE; PATHOGENESIS; REVIEW; ANIMAL; BIOLOGICAL MODEL; DRUG DESIGN; GENETICS; METABOLISM;

ANIMALS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE MODELS, ANIMAL; DRUG DESIGN; MODELS, BIOLOGICAL;

EID: 85029555711     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2017.09.001     Document Type: Review

References (86)

1. Keiser, N.W., Engelhardt, J.F., New animal models of cystic fibrosis: what are they teaching us?. Curr Opin Pulm Med 17:6 (2011), 478–483.
2. Guilbault, C., Saeed, Z., Downey, G.P., Radzioch, D., Cystic fibrosis mouse models. Am J Respir Cell Mol Biol 36:1 (2007), 1–7.
3. Tuggle, K.L., Birket, S.E., Cui, X., Hong, J., Warren, J., Reid, L., et al. Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout rats. PLoS One, 9(3), 2014, e91253.
4. Xu, J., Rajagopolan, C., Hou, X., Chen, E., Boucher, R.C., Sun, F., Rabbit models for cystic fibrosis. Pediatr Pulmonol 51 (2016), A158–9.
5. Rogers, C.S., Hao, Y., Rokhlina, T., Samuel, M., Stoltz, D.A., Li, Y., et al. Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer. J Clin Invest 118:4 (2008), 1571–1577.
6. Sun, X., Yan, Z., Yi, Y., Li, Z., Lei, D., Rogers, C.S., et al. Adeno-associated virus-targeted disruption of the CFTR gene in cloned ferrets. J Clin Invest 118:4 (2008), 1578–1583.
7. Rogers, C.S., Stoltz, D.A., Meyerholz, D.K., Ostedgaard, L.S., Rokhlina, T., Taft, P.J., et al. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321:5897 (2008), 1837–1841.
8. Sun, X., Sui, H., Fisher, J.T., Yan, Z., Liu, X., Cho, H.J., et al. Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J Clin Invest 120:9 (2010), 3149–3160.
9. Stoltz, D.A., Meyerholz, D.K., Pezzulo, A.A., Ramachandran, S., Rogan, M.P., Davis, G.J., et al. Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med, 2(29), 2010, 29ra31.
10. Sun, X., Olivier, A.K., Liang, B., Yi, Y., Sui, H., Evans, T.I., et al. Lung phenotype of juvenile and adult cystic fibrosis transmembrane conductance regulator-knockout ferrets. Am J Respir Cell Mol Biol 50:3 (2014), 502–512.
11. Sun, X., Olivier, A.K., Yi, Y., Pope, C.E., Hayden, H.S., Liang, B., et al. Gastrointestinal pathology in juvenile and adult CFTR-knockout ferrets. Am J Pathol 184:5 (2014), 1309–1322.
12. Parent, R.A., Comparative biology of the normal lung. 2015, Elsevier/AP, Academic Press is an imprint of Elsevier, Amsterdam; Boston.
13. Snouwaert, J.N., Brigman, K.K., Latour, A.M., Malouf, N.N., Boucher, R.C., Smithies, O., et al. An animal model for cystic fibrosis made by gene targeting. Science 257:5073 (1992), 1083–1088.
14. Dorin, J.R., Dickinson, P., Alton, E.W., Smith, S.N., Geddes, D.M., Stevenson, B.J., et al. Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature 359:6392 (1992), 211–215.
15. Grubb, B.R., Boucher, R.C., Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev 79:1 Suppl (1999), S193–214.
16. Heeckeren, A., Walenga, R., Konstan, M.W., Bonfield, T., Davis, P.B., Ferkol, T., Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest 100:11 (1997), 2810–2815.
17. van Heeckeren, A.M., Davis, P.B., Examining the contribution of resident and migratory cells in mediating the exaggerated inflammatory response in cystic fibrosis lung infections with mucoid P. aeruginosa. Pediatr Pulmonol, 38(S27), 2004, 274.
18. + absorption produces cystic fibrosis-like lung disease in mice. Nat Med 10:5 (2004), 487–493.
19. Zhou-Suckow, Z., Duerr, J., Hagner, M., Agrawal, R., Mall, M.A., Airway mucus, inflammation and remodeling: emerging links in the pathogenesis of chronic lung diseases. Cell Tissue Res 367:3 (2017), 537–550.
20. Hoegger, M.J., Fischer, A.J., McMenimen, J.D., Ostedgaard, L.S., Tucker, A.J., Awadalla, M.A., et al. Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis. Science 345:6198 (2014), 818–822.
21. Keiser, N.W., Birket, S.E., Evans, I.A., Tyler, S.R., Crooke, A.K., Sun, X., et al. Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs. Am J Respir Cell Mol Biol 52:6 (2015), 683–694.
22. Hoegger, M.J., Awadalla, M., Namati, E., Itani, O.A., Fischer, A.J., Tucker, A.J., et al. Assessing mucociliary transport of single particles in vivo shows variable speed and preference for the ventral trachea in newborn pigs. Proc Natl Acad Sci U S A 111:6 (2014), 2355–2360.
23. Peng, X., Alfoldi, J., Gori, K., Eisfeld, A.J., Tyler, S.R., Tisoncik-Go, J., et al. The draft genome sequence of the ferret (Mustela putorius furo) facilitates study of human respiratory disease. Nat Biotechnol 32:12 (2014), 1250–1255.
24. Abou Alaiwa, M.H., Launspach, J.L., Sheets, K.A., Rivera, J.A., Gansemer, N.D., Taft, P.J., et al. Repurposing tromethamine as inhaled therapy to treat CF airway disease. JCI Insight, 1(8), 2016.
25. Shah, V.S., Meyerholz, D.K., Tang, X.X., Reznikov, L., Abou Alaiwa, M., Ernst, S.E., et al. Airway acidification initiates host defense abnormalities in cystic fibrosis mice. Science 351:6272 (2016), 503–507.
26. Yan, Z., Stewart, Z.A., Sinn, P.L., Olsen, J.C., Hu, J., McCray, P.B. Jr., et al. Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy. Hum Gene Ther Clin Dev 26:1 (2015), 38–49.
27. Steines, B., Dickey, D.D., Bergen, J., Excoffon, K.J., Weinstein, J.R., Li, X., et al. CFTR gene transfer with AAV improves early cystic fibrosis pig phenotypes. JCI Insight, 1(14), 2016, e88728.
28. Cooney, A.L., Abou Alaiwa, M.H., Shah, V.S., Bouzek, D.C., Stroik, M.R., Powers, L.S., et al. Lentiviral-mediated phenotypic correction of cystic fibrosis pigs. JCI Insight, 1(14), 2016.
29. Abu-El-Haija, M., Ramachandran, S., Meyerholz, D.K., Abu-El-Haija, M., Griffin, M., Giriyappa, R.L., et al. Pancreatic damage in fetal and newborn cystic fibrosis pigs involves the activation of inflammatory and remodeling pathways. Am J Pathol 181:2 (2012), 499–507.
30. Abu-El-Haija, M., Sinkora, M., Meyerholz, D.K., Welsh, M.J., McCray, P.B. Jr., Butler, J., et al. An activated immune and inflammatory response targets the pancreas of newborn pigs with cystic fibrosis. Pancreatology 11:5 (2011), 506–515.
31. Olivier, A.K., Yi, Y., Sun, X., Sui, H., Liang, B., Hu, S., et al. Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets. J Clin Invest 122:10 (2012), 3755–3768.
32. Uc, A., Olivier, A.K., Griffin, M.A., Meyerholz, D.K., Yao, J., Abu-El-Haija, M., et al. Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass. Clin Sci (Lond) 128:2 (2015), 131–142.
33. Yi, Y., Sun, X., Gibson-Corley, K., Xie, W., Liang, B., He, N., et al. A transient metabolic recovery from early life glucose intolerance in cystic fibrosis ferrets occurs during pancreatic remodeling. Endocrinology 157:5 (2016), 1852–1865.
34. Yi, Y., Norris, A.W., Wang, K., Sun, X., Uc, A., Moran, A., et al. Abnormal glucose tolerance in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 194:8 (2016), 974–980.
35. Olivier, A.K., Gibson-Corley, K.N., Meyerholz, D.K., Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology. Am J Physiol Gastrointest Liver Physiol 308:6 (2015), G459–71.
36. Colombo, C., Battezzati, P.M., Crosignani, A., Morabito, A., Costantini, D., Padoan, R., et al. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology 36:6 (2002), 1374–1382.
37. Lamireau, T., Monnereau, S., Martin, S., Marcotte, J.E., Winnock, M., Alvarez, F., Epidemiology of liver disease in cystic fibrosis: a longitudinal study. J Hepatol 41:6 (2004), 920–925.
38. Debray, D., Kelly, D., Houwen, R., Strandvik, B., Colombo, C., Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros 10:Suppl. 2 (2011), S29–36.
39. Wilke, M., Buijs-Offerman, R.M., Aarbiou, J., Colledge, W.H., Sheppard, D.N., Touqui, L., et al. Mouse models of cystic fibrosis: phenotypic analysis and research applications. J Cyst Fibros 10:Suppl. 2 (2011), S152–71.
40. Uc, A., Giriyappa, R., Meyerholz, D.K., Griffin, M., Ostedgaard, L.S., Tang, X.X., et al. Pancreatic and biliary secretion are both altered in cystic fibrosis pigs. Am J Physiol Gastrointest Liver Physiol 303:8 (2012), G961–8.
41. Fisher, J.T., Tyler, S.R., Zhang, Y., Lee, B.J., Liu, X., Sun, X., et al. Bioelectric characterization of epithelia from neonatal CFTR knockout ferrets. Am J Respir Cell Mol Biol 49:5 (2013), 837–844.
42. Scott-Jupp, R., Lama, M., Tanner, M.S., Prevalence of liver disease in cystic fibrosis. Arch Dis Child 66:6 (1991), 698–701.
43. Lindblad, A., Glaumann, H., Strandvik, B., Natural history of liver disease in cystic fibrosis. Hepatology 30:5 (1999), 1151–1158.
44. Scher, H., Bishop, W.P., McCray, P.B. Jr., Ursodeoxycholic acid improves cholestasis in infants with cystic fibrosis. Ann Pharmacother 31:9 (1997), 1003–1005.
45. Harrison, P.T., Sanz, D.J., Hollywood, J.A., Impact of gene editing on the study of cystic fibrosis. Hum Genet 135:9 (2016), 983–992.
46. Barrangou, R., Cas9 targeting and the CRISPR revolution. Science 344:6185 (2014), 707–708.
47. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A., Charpentier, E., A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:6096 (2012), 816–821.
48. Firth, A.L., Menon, T., Parker, G.S., Qualls, S.J., Lewis, B.M., Ke, E., et al. Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs. Cell Rep 12:9 (2015), 1385–1390.
49. Randell, S.H., Fulcher, M.L., O'Neal, W., Olsen, J.C., Primary epithelial cell models for cystic fibrosis research. Methods Mol Biol 742 (2011), 285–310.
50. Crespin, S., Bacchetta, M., Huang, S., Dudez, T., Wiszniewski, L., Chanson, M., Approaches to study differentiation and repair of human airway epithelial cells. Methods Mol Biol 742 (2011), 173–185.
51. Wansleeben, C., Barkauskas, C.E., Rock, J.R., Hogan, B.L.M., Stem cells of the adult lung: their development and role in homeostasis, regeneration, and disease. Wires Dev Biol 2:1 (2013), 131–148.
52. Bellec, J., Bacchetta, M., Losa, D., Anegon, I., Chanson, M., Nguyen, T.H., CFTR inactivation by lentiviral vector-mediated RNA interference and CRISPR-Cas9 genome editing in human airway epithelial cells. Curr Gene Ther 15:5 (2015), 447–459.
53. Chung, W.Y., Song, M., Park, J., Namkung, W., Lee, J., Kim, H., et al. Generation of Delta F508-CFTR T84 cell lines by CRISPR/Cas9-mediated genome editing. Biotechnol Lett 38:12 (2016), 2023–2034.
54. Dekkers, J.F., Wiegerinck, C.L., de Jonge, H.R., Bronsveld, I., Janssens, H.M., de Winter-de Groot, K.M., et al. A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nat Med, 19(7), 2013, 939-+.
55. Tan, Q., Choi, K.M., Sicard, D., Tschumperlin, D.J., Human airway organoid engineering as a step toward lung regeneration and disease modeling. Biomaterials 113 (2017), 118–132.
56. Schwank, G., Koo, B.K., Sasselli, V., Dekkers, J.F., Heo, I., Demircan, T., et al. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 13:6 (2013), 653–658.
57. Cianci, E., Recchiuti, A., Trubiani, O., Diomede, F., Marchisio, M., Miscia, S., et al. Human periodontal stem cells release specialized proresolving mediators and carry immunomodulatory and prohealing properties regulated by lipoxins. Stem Cells Transl Med 5:1 (2016), 20–32.
58. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282:5391 (1998), 1145–1147.
59. Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:4 (2006), 663–676.
60. Martin, U., Pluripotent stem cells for disease modeling and drug screening: new perspectives for treatment of cystic fibrosis?. Mol Cell Pediatr, 2(1), 2015, 15.
61. Wong, A.P., Chin, S., Xia, S., Garner, J., Bear, C.E., Rossant, J., Efficient generation of functional CFTR-expressing airway epithelial cells from human pluripotent stem cells. Nat Protoc, 10(3), 2015.
62. Firth, A.L., Dargitz, C.T., Qualls, S.J., Menon, T., Wright, R., Singer, O., et al. Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells. Proc Natl Acad Sci U S A, 111(17), 2014, E1723-E30.
63. Mou, H.M., Zhao, R., Sherwood, R., Ahfeldt, T., Lapey, A., Wain, J., et al. Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs. Cell Stem Cell 10:4 (2012), 385–397.
64. McCauley, K.B., Hawkins, F., Serra, M., Thomas, D.C., Jacob, A., Kotton, D.N., Efficient derivation of functional human airway epithelium from pluripotent stem cells via temporal regulation of Wnt signaling. Cell Stem Cell, 20(6), 2017, 844-+.
65. Schedl, A., Montoliu, L., Kelsey, G., Schutz, G., A yeast artificial chromosome covering the tyrosinase gene confers copy number-dependent expression in transgenic mice. Nature 362:6417 (1993), 258–261.
66. Strauss, W.M., Dausman, J., Beard, C., Johnson, C., Lawrence, J.B., Jaenisch, R., Germ line transmission of a yeast artificial chromosome spanning the murine alpha 1(I) collagen locus. Science 259:5103 (1993), 1904–1907.
67. Jakobovits, A., Moore, A.L., Green, L.L., Vergara, G.J., Maynard-Currie, C.E., Austin, H.A., et al. Germ-line transmission and expression of a human-derived yeast artificial chromosome. Nature 362:6417 (1993), 255–258.
68. Lamb, B.T., Sisodia, S.S., Lawler, A.M., Slunt, H.H., Kitt, C.A., Kearns, W.G., et al. Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected]. Nat Genet 5:1 (1993), 22–30.
69. Pearson, B.E., Choi, T.K., Expression of the human beta-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice. Proc Natl Acad Sci U S A 90:22 (1993), 10578–10582.
70. Loring, J.F., Paszty, C., Rose, A., McIntosh, T.K., Murai, H., Pierce, J.E., et al. Rational design of an animal model for Alzheimer's disease: introduction of multiple human genomic transgenes to reproduce AD pathology in a rodent. Neurobiol Aging 17:2 (1996), 173–182.
71. Lamb, B.T., Call, L.M., Slunt, H.H., Bardel, K.A., Lawler, A.M., Eckman, C.B., et al. Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice. Hum Mol Genet 6:9 (1997), 1535–1541.
72. Lamb, B.T., Bardel, K.A., Kulnane, L.S., Anderson, J.J., Holtz, G., Wagner, S.L., et al. Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice. Nat Neurosci 2:8 (1999), 695–697.
73. Van Raamsdonk, J.M., Warby, S.C., Hayden, M.R., Selective degeneration in YAC mouse models of Huntington disease. Brain Res Bull 72:2–3 (2007), 124–131.
74. Fan, J., Gladding, C.M., Wang, L., Zhang, L.Y., Kaufman, A.M., Milnerwood, A.J., et al. P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease. Neurobiol Dis 45:3 (2012), 999–1009.
75. Musumeci, S.A., Calabrese, G., Bonaccorso, C.M., D'Antoni, S., Brouwer, J.R., Bakker, C.E., et al. Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes. Exp Neurol 203:1 (2007), 233–240.
76. Rachidi, M., Lopes, C., Vayssettes, C., Smith, D.J., Rubin, E.M., Delabar, J.M., New cerebellar phenotypes in YAC transgenic mouse in vivo library of human Down syndrome critical region-1. Biochem Biophys Res Commun 364:3 (2007), 488–494.
77. Seo, H., Isacson, O., The hAPP-YAC transgenic model has elevated UPS activity in the frontal cortex similar to Alzheimer's disease and Down's syndrome. J Neurochem 114:6 (2010), 1819–1826.
78. Butzler, C., Zou, X., Popov, A.V., Bruggemann, M., Rapid induction of B-cell lymphomas in mice carrying a human IgH/c-mycYAC. Oncogene 14:11 (1997), 1383–1388.
79. Palomo, C., Zou, X., Nicholson, I.C., Butzler, C., Bruggemann, M., B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu). Cancer Res 59:21 (1999), 5625–5628.
80. Green, L.L., Hardy, M.C., Maynard-Currie, C.E., Tsuda, H., Louie, D.M., Mendez, M.J., et al. Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nat Genet 7:1 (1994), 13–21.
81. Pruzina, S., Williams, G.T., Kaneva, G., Davies, S.L., Martin-Lopez, A., Bruggemann, M., et al. Human monoclonal antibodies to HIV-1 gp140 from mice bearing YAC-based human immunoglobulin transloci. Protein Eng Des Sel 24:10 (2011), 791–799.
82. Chang, J.C., Lu, R., Lin, C., Xu, S.M., Kan, Y.W., Porcu, S., et al. Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: a mouse model of sickle cell anemia. Proc Natl Acad Sci U S A 95:25 (1998), 14886–14890.
83. Ye, L., Chang, J.C., Lu, R., Kan, Y.W., High oxygen environment during pregnancy rescues sickle cell anemia mice from prenatal death. Blood Cells Mol Dis 41:1 (2008), 67–72.
84. Klymiuk, N., Mundhenk, L., Kraehe, K., Wuensch, A., Plog, S., Emrich, D., et al. Sequential targeting of CFTR by BAC vectors generates a novel pig model of cystic fibrosis. J Mol Med 90:5 (2012), 597–608.
85. Manson, A.L., Trezise, A.E., MacVinish, L.J., Kasschau, K.D., Birchall, N., Episkopou, V., et al. Complementation of null CF mice with a human CFTR YAC transgene. EMBO J 16:14 (1997), 4238–4249.
86. Gawenis, L.R., Walker, N.M., Strubberg, A.M., Harris, A., Clarke, L.L., Generation of BAC transgenic mice expressing human CFTR. Pediatr Pulmonol, 50(12), 2015, A86.